Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01132547 · OUTCOME

Severity of Weight Loss

Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer · Source last updated 2015-07-02

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEAN
Unit
Z score
Interval / dispersion
Standard Deviation
Time frame
Baseline and 8 weeks

What was measured

Change from Baseline in Weight Z score

Analysis population: Completers =

Groups in this outcome

Arm I Cyproheptadine Hydrochloride

Patients receive oral cyproheptadine hydrochloride twice daily for 8 weeks. cyproheptadine hydrochloride: Given orally

Arm II Placebo

Patients receive an oral placebo twice daily for 8 weeks. placebo: Given orally

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Arm I Cyproheptadine Hydrochloride5
Arm II Placebo12

Reported measurements

Source class 1
Values in Z score · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
Arm I Cyproheptadine Hydrochloride0.121.15Not reportedNot reportedNot reported
Arm II Placebo-0.020.30Not reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        spread
        1.15
        value
        0.12
      2. group Id
        OG001
        spread
        0.30
        value
        -0.02
denoms
  1. counts
    1. group Id
      OG000
      value
      5
    2. group Id
      OG001
      value
      12
    units
    Participants
description
Change from Baseline in Weight Z score
dispersion Type
Standard Deviation
groups
  1. description
    Patients receive oral cyproheptadine hydrochloride twice daily for 8 weeks. cyproheptadine hydrochloride: Given orally
    id
    OG000
    title
    Arm I Cyproheptadine Hydrochloride
  2. description
    Patients receive an oral placebo twice daily for 8 weeks. placebo: Given orally
    id
    OG001
    title
    Arm II Placebo
param Type
MEAN
population Description
Completers =
reporting Status
POSTED
time Frame
Baseline and 8 weeks
title
Severity of Weight Loss
type
PRIMARY
unit Of Measure
Z score

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice